Circulating free RNA (cfRNA) as a predictive tool for immunotherapy benefit in mismatch-repair-deficient colorectal cancer (dMMR CRC). This is an ASCO Meeting Abstract from the 2026 ASCO ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results